Latest Regulatory Approvals News

Marquee Resources has identified significant gold anomalies across its 106 km² Yindi Gold Project in Western Australia, backed by a thorough review of historical drilling data. The company plans targeted drilling to validate promising intercepts near major gold operations.

Kincora Copper announces a C$4 million private placement backed by prominent North American investors, alongside a planned 10-for-1 share consolidation to accelerate exploration at its Condobolin project.

Sun Silver Limited has obtained regulatory approval for 90 additional drill pads at its Maverick Springs Silver-Gold Project in Nevada, enabling uninterrupted drilling to support resource upgrades and metallurgical testing through 2025.

Nova Minerals has filed a Form F-1 registration statement with the U.S. SEC for a secondary offering of its American Depositary Shares, aiming to raise capital for advancing its Estelle Project in Alaska.

Almonty Industries has filed for a Nasdaq listing and launched a U.S. public offering to fund its tungsten oxide facility and strengthen its global supply position amid rising geopolitical tensions.

Cochlear Limited has secured FDA approval for its latest Nucleus Nexa System and Kanso 3 sound processors, setting the stage for a US market debut in early FY26.

Laramide Resources has expanded its private placement to raise up to $12 million, aiming to fast-track US permitting and strengthen its balance sheet. The move signals confidence in advancing its late-stage uranium projects amid a competitive market.

TPG Telecom has received Foreign Investment Review Board approval to sell its fibre and fixed Enterprise, Government and Wholesale assets to Vocus for $5.25 billion, marking a pivotal step in its strategic reshaping.

Zeus Resources has completed the acquisition of the Casablanca Antimony Project in Morocco, unlocking access to exceptionally high-grade antimony mineralisation and positioning itself in a mining-friendly jurisdiction.

EVE Health Group has placed its first commercial purchase order for Dyspro™, a cannabinoid-based pharmaceutical targeting painful menstruation, signaling a key step toward market entry. The product is set for manufacturing and distribution within weeks, tapping into a rapidly growing global women’s health market.

MIXI Australia has secured crucial gaming approvals from Ontario regulators, removing a major obstacle in its proposed takeover of PointsBet Holdings. The bid now awaits shareholder acceptance to proceed.

Nanosonics has launched trophon3, its next-generation ultrasound disinfection device, alongside a software upgrade for existing users, promising faster cycles and enhanced digital integration.